News
Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare ...
The candidates are sourced from Arnatar’s next-gen RNA discovery engine, dubbed DARGER for dual-functional antisense RNA for ...
The San Diego, USA firm has simultaneously announced that the US Food and Drug Administration (FDA) has granted Orphan Drug ...
Researchers at San Diego State University and Michigan State University are shedding new light on how viruses meticulously ...
Circurna Engages GATC Health for AI-Powered Discovery to Accelerate ciRNA™ Circular RNA Therapeutics
Circurna, ( a biotechnology company advancing its proprietary ciRNA™ circular RNA platform, and GATC Health, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug ...
RNA-binding proteins use a dual binding mechanism involving zinc finger (ZnF) domains and intrinsically disordered regions ...
The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...
20h
Zacks Investment Research on MSNRNA Stock Moves More Than 30% in a Week: What's Driving This Rally?
Shares of Avidity Biosciences RNA have soared 36% in the past month, all thanks to a report issued by the Financial Times (FT ...
RNA-binding proteins use a dual binding mechanism involving zinc finger (ZnF) domains and intrinsically disordered regions ...
In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...
DNA’s chemical cousin, RNA, was the messenger that carries DNA instructions from the double helix in the cell’s nucleus to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results